Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paola Pegoraro"'
Autor:
Sonia Pankl, Ana Meraldi, Paola Pegoraro, Geofredo Earsman, Julio E Bruetman, José Ceresetto, Martín Bosio, Gustavo Lyons, Pablo Young
Publikováno v:
Medicina (Buenos Aires), Vol 75, Iss 2, Pp 95-98 (2015)
El síndrome de Hughes-Stovin es una entidad infrecuente caracterizada por trombosis venosa profunda y aneurismas de la arteria pulmonar, siendo su etiología y patogenia desconocida. Algunos autores la consideran una variante de la enfermedad de Beh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::ea5d46b7da9fe62b2bfdd416c4ba817f
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802015000200005&lng=en&tlng=en
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802015000200005&lng=en&tlng=en
Publikováno v:
Clinical Pharmacology & Therapeutics. 85:319-326
In this study, quinine was used as a probe substrate and erythromycin as a prototypical irreversible inhibitor of CYP3A to ascertain whether, like reversible CYP inhibition, the magnitude of irreversible inhibition is also strictly dependent on the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c5772fe008a79545ee55c2840e8ee40
https://doi.org/10.1038/clpt.2008.216
https://doi.org/10.1038/clpt.2008.216
Autor:
Sonia, Pankl, Ana, Meraldi, Paola, Pegoraro, Geofredo, Earsman, Julio E, Bruetman, José, Ceresetto, Martín, Bosio, Gustavo, Lyons, Pablo, Young
Publikováno v:
Medicina. 75(2)
The Hughes-Stovin syndrome is a rare entity characterized by deep vein thrombosis and pulmonary artery aneurysms of unknown etiology and pathogenesis. Some authors considered a variant of Behcet's disease. Its natural course is usually fatal. The sym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53a56dc98dd6fd99bdc53c2a2ea76e24
https://pubmed.ncbi.nlm.nih.gov/25919871
https://pubmed.ncbi.nlm.nih.gov/25919871
Publikováno v:
Current clinical pharmacology. 3(1)
This article reviews the influence of liver functional status on pharmacokinetic interactions due to inhibition and induction of drug-metabolizing enzymes. Recent human studies have shown that the magnitude of inhibitory interactions caused by the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff50c84a6ef3840319f5d0952d4efd0a
https://pubmed.ncbi.nlm.nih.gov/18690879
https://pubmed.ncbi.nlm.nih.gov/18690879
Background and Objectives The effect of chronic renal failure (CRF) on the pharmacokinetics of lidocaine, a drug cleared almost exclusively by hepatic metabolism, has thus far only been evaluated in patients undergoing regular hemodialysis. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aba9b9d33a04c9bd8a3832b2ab2013f6
http://hdl.handle.net/11577/2447285
http://hdl.handle.net/11577/2447285
